| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8656659 | Atherosclerosis | 2018 | 9 Pages |
Abstract
Ticagrelor attenuated vascular dysfunction and atherogenesis through the inhibition of inflammatory activation of endothelial cells. These effects might be a potential mechanism by which ticagrelor decreases cardiovascular events in patients with ACS.
Keywords
qPCRP2Y12VCAM-1CTRLACSICAM-1WTDHUVECMCP-1ADPApoE−/−Atherosclerosisadenosine diphosphateAChAcetylcholineinflammationticagrelorEndothelial functionWestern-type dietHuman umbilical vein endothelial cellAcute coronary syndromeintercellular adhesion molecule-1vascular cell adhesion molecule-1wild-typesodium nitroprussidequantitative real-time PCRmonocyte chemoattractant protein-1SNPControl
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Byambasuren Ganbaatar, Daiju Fukuda, Hotimah Masdan Salim, Sachiko Nishimoto, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Shusuke Yagi, Takeshi Soeki, Masataka Sata,